Yue He Selected Research

salicylhydroxamic acid (SHAM)

10/2021	Superficial Needling Acupuncture vs Sham Acupuncture for Knee Osteoarthritis: A Randomized Controlled Trial.
1/2016	Hyperbaric Oxygen Preconditioning Attenuates Hemorrhagic Transformation Through Reactive Oxygen Species/Thioredoxin-Interacting Protein/Nod-Like Receptor Protein 3 Pathway in Hyperglycemic Middle Cerebral Artery Occlusion Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yue He Research Topics

Disease

49	Neoplasms (Cancer) 05/2022 - 09/2007
12	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2022 - 12/2013
9	Brain Injuries (Brain Injury) 01/2021 - 09/2009
9	Inflammation (Inflammations) 09/2019 - 02/2005
8	Squamous Cell Carcinoma of Head and Neck 01/2022 - 01/2013
7	Hemorrhage 05/2021 - 12/2013
7	Carcinoma (Carcinomatosis) 01/2019 - 09/2007
6	Wounds and Injuries (Trauma) 10/2022 - 12/2013
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2022 - 12/2013
6	Osteoradionecrosis 03/2020 - 12/2008
5	Carcinogenesis 01/2021 - 04/2013
5	Ischemic Stroke 01/2021 - 01/2014
5	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 02/2016 - 08/2015
4	Infections 04/2021 - 01/2015
4	Neuroinflammatory Diseases 01/2021 - 08/2015
4	Fibrosis (Cirrhosis) 01/2021 - 12/2015
4	Uterine Cervicitis (Cervicitis) 03/2019 - 08/2012
4	Glioma (Gliomas) 01/2019 - 03/2006
4	Pancreatitis 01/2018 - 05/2016
3	Diabetes Mellitus 08/2022 - 02/2015
3	Neoplasm Metastasis (Metastasis) 07/2022 - 03/2015
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2022 - 09/2021
3	Aneurysm (Aneurysms) 01/2022 - 08/2008
3	Margins of Excision 07/2021 - 09/2014
3	Mouth Neoplasms (Oral Cancer) 01/2021 - 02/2015
3	Stroke (Strokes) 01/2021 - 01/2021
3	Hemorrhagic Stroke 01/2021 - 01/2014
3	Ischemia 09/2019 - 02/2016
3	Hypertension (High Blood Pressure) 01/2018 - 02/2016
3	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 09/2007
3	Urinary Bladder Neoplasms (Bladder Cancer) 06/2016 - 06/2014
3	Necrosis 05/2016 - 11/2014
2	COVID-19 12/2022 - 06/2020
2	Lung Neoplasms (Lung Cancer) 07/2022 - 03/2020
2	Thrombocytopenia (Thrombopenia) 03/2022 - 01/2022
2	Testicular Neoplasms (Testicular Cancer) 01/2022 - 09/2021
2	Sepsis (Septicemia) 01/2022 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 02/2016
2	Knee Osteoarthritis 10/2021 - 09/2021
2	Pre-Eclampsia (Preeclampsia) 01/2021 - 01/2019
2	Cicatrix (Scar) 01/2021 - 02/2015
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 07/2011
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2020
2	Glioblastoma (Glioblastoma Multiforme) 12/2020 - 01/2019
2	Hydrocephalus (Hydrocephaly) 01/2020 - 02/2005

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 10/2022 - 03/2006
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2011
7	MicroRNAs (MicroRNA)IBA 05/2022 - 06/2014
7	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 02/2013
5	Paclitaxel (Taxol)FDA LinkGeneric 10/2020 - 01/2016
4	Messenger RNA (mRNA)IBA 01/2022 - 03/2006
4	Biological ProductsIBA 01/2022 - 09/2009
4	AntigensIBA 01/2022 - 01/2015
4	Pharmaceutical PreparationsIBA 10/2021 - 03/2013
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2016
4	Docetaxel (Taxotere)FDA Link 01/2021 - 02/2013
4	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 02/2013
4	Small Interfering RNA (siRNA)IBA 02/2016 - 08/2015
3	VaccinesIBA 12/2022 - 01/2015
3	Retinaldehyde (Retinal)IBA 08/2022 - 03/2015
3	Inosine Triphosphate (ITP)IBA 03/2022 - 09/2021
3	Long Noncoding RNAIBA 01/2022 - 01/2021
3	Antimicrobial PeptidesIBA 10/2021 - 05/2016
3	Vitamin D FDA LinkGeneric 09/2021 - 02/2016
3	Peroxidase (Myeloperoxidase)IBA 01/2017 - 05/2016
3	Amylases FDA Link 01/2017 - 05/2016
3	VimentinIBA 06/2016 - 11/2010
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 03/2015 - 08/2010
3	Tumor Biomarkers (Tumor Markers)IBA 03/2015 - 07/2011
2	Epidermal Growth Factor (EGF)IBA 10/2022 - 10/2015
2	Glucose (Dextrose)FDA LinkGeneric 08/2022 - 01/2016
2	Carboplatin (JM8)FDA LinkGeneric 04/2022 - 05/2020
2	p38 Mitogen-Activated Protein KinasesIBA 04/2022 - 02/2016
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2022
2	salicylhydroxamic acid (SHAM)IBA 10/2021 - 01/2016
2	3' Untranslated Regions (3' UTR)IBA 05/2021 - 01/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2021 - 11/2020
2	Immune Checkpoint InhibitorsIBA 01/2021 - 03/2020
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021 - 01/2013
2	ImmunosorbentsIBA 01/2021 - 01/2019
2	EnzymesIBA 01/2021 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 12/2020 - 09/2009
2	HydrogelsIBA 11/2020 - 10/2020
2	Peptides (Polypeptides)IBA 11/2020 - 10/2020
2	MesothelinIBA 01/2020 - 03/2019

Therapy/Procedure

18	Therapeutics 10/2021 - 12/2013
11	Radiotherapy 01/2021 - 07/2011
5	Drug Therapy (Chemotherapy) 04/2022 - 04/2014
4	Induction Chemotherapy 01/2021 - 02/2013
4	Neoadjuvant Therapy 08/2020 - 06/2018
3	Transplantation 01/2021 - 09/2009
3	Injections 10/2020 - 05/2016
3	Hysterectomy 03/2019 - 09/2014
3	Mandibular Osteotomy 05/2011 - 12/2008
2	Aftercare (After-Treatment) 01/2022 - 07/2021
2	Anesthesia 01/2022 - 04/2021
2	Stents 01/2022 - 08/2008
2	Ligation 01/2021 - 02/2018
2	Myocutaneous Flap 03/2020 - 12/2008
2	Conservative Treatment 01/2020 - 09/2014